Frequency Therapeutics, Inc.

... ...
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 6.27%132.980.0%$2570.66m
BNGOBioNano Genomics, Inc. 2.73%8.270.0%$1690.46m
GILDGilead Sciences, Inc. -1.49%66.981.0%$662.69m
AMGNAmgen, Inc. -0.13%252.031.3%$559.93m
CRSPCRISPR Therapeutics AG -2.46%185.100.6%$485.98m
ALXNAlexion Pharmaceuticals, Inc. 0.08%157.862.0%$476.83m
REGNRegeneron Pharmaceuticals, Inc. -1.25%535.482.7%$473.91m
NVAXNovavax, Inc. -2.12%122.4092.9%$428.82m
ILMNIllumina, Inc. 0.33%404.873.5%$394.29m
VRTXVertex Pharmaceuticals, Inc. 0.82%238.641.9%$360.42m
SRPTSarepta Therapeutics, Inc. 0.17%96.9213.8%$356.59m
BIIBBiogen, Inc. -0.06%270.121.7%$326.66m
BNTXBioNTech SE 2.13%105.430.0%$299.54m
EXASEXACT Sciences Corp. -1.53%148.0719.6%$239.88m
PACBPacific Biosciences of California, Inc. -5.90%36.317.4%$230.80m

Company Profile

Frequency Therapeutics, Inc. engages in the development of small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Its product pipeline include Sensorineural hearing loss (FX-322), and Multiple Sclerosis. The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean on November 13, 2014 and is headquartered in Woburn, MA.